Picture of Mauna Kea Technologies SA logo

ALMKT — Mauna Kea Technologies SA News Story

0.000.00%
fr flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapNeutral

Brief: Mauna Kea Technologies Announces Strategic Equity Investment Of 7.5 Million Euros

Dec 16 (Reuters) - MAUNA KEA TECHNOLOGIES SAS  MKEA.PA :
    * MAUNA KEA TECHNOLOGIES ANNOUNCES STRATEGIC EQUITY
INVESTMENT OF
EUR 7.5 MILLION BY JOHNSON & JOHNSON INNOVATION
    * PURSUANT TO THE AGREEMENT, JJDC WILL SUBSCRIBE TO
5,357,142 NEW
ORDINARY MKEA SHARES FOR €1.40 PER SHARE, REPRESENTING A TOTAL
EQUITY VALUE OF 7.5 MILLION EURO.
    * NEW ORDINARY SHARES WILL BE FUNGIBLE WITH EXISTING SHARES
OF
COMPANY
    * JJDC WILL OWN APPROXIMATELY 17.5% OF TOTAL ORDINARY SHARES
OUTSTANDING FOLLOWING THIS TRANSACTION
    * JJDC WILL NOT HAVE ANY BOARD REPRESENTATION RIGHTS
    * NET PROCEEDS WILL BE USED TO FURTHER DEVELOP THE CELLVIZIO
PLATFORM, PURSUE CLINICAL STUDIES AND INTENSIFY SALES AND
MARKETING EFFORTS IN THE UNITED STATES
    * EXPECTS NET PROCEEDS FROM THE SHARE CAPITAL INCREASE,
COMBINED
WITH ITS CURRENT OPERATING CAPITAL, TO ENABLE THE FUNDING OF ITS
OPERATIONS UNTIL THE END OF 2020
    * AS PART OF INVESTMENT, JJDC AGREED TO CUSTOMARY LOCK UP
AND
STAND STILL OBLIGATIONS FOR A PERIOD OF 12 MONTHS
    * PIPER JAFFRAY IS ACTING AS STRATEGIC ADVISOR AND MCDERMOTT
WILL
& EMERY IS ACTING AS LEGAL ADVISOR TO MAUNA KEA TECHNOLOGIES
    * CLOSING OF TRANSACTION IS EXPECTED TO OCCUR ON DECEMBER
19, 2019

Source text for Eikon:  ID:nBw3lDc40a 
Further company coverage:  MKEA.PA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48587785110;))

Recent news on Mauna Kea Technologies SA

See all news